Carl Ola Landgren MD, PhD

Dr. Carl Ola Landgren is Professor of Medicine, Chief of the Myeloma Division, and Co-Leader of the Translational and Clinical Oncology (TCO) Program at the NCI-designated Sylvester Comprehensive Cancer Center (Sylvester). In his Co-Leader role, he works closely with Dr. Jaime Merchan to oversee the clinical and research operations for TCO, as well as the development of the research program. Dr. Merchan and he complement each other's talents and strengths and serve as key conduits to move science from the lab into the clinic, and vice versa. As a Cancer Center Support Grant member, he participates in research activities as an independent investigator, as a leader of research governance committees, and serves on multidisciplinary research teams.

He is a frequent speaker and faculty member at national and international meetings on myeloma and hematologic malignancies. He serves on the editorial boards of Hemasphere, Leukemia, and Blood Advances, and is a reviewer for grants and several high-impact journals.